M02.01.001 The Basal Ganglia

Written by

in

Learning Objectives

By the end of this session, the learner will be able to describe the anatomical components of the basal ganglia and their ipsilateral organization, explain the concept of disinhibition in the direct and indirect pathways, differentiate D1 vs D2 receptor modulation by dopamine, correlate lesions with hypokinetic vs hyperkinetic disorders, and identify key features and treatments of major movement disorders.

1. Structural Neuroanatomy

The basal ganglia initiate and regulate voluntary movement. Key Principle: All basal ganglia circuits are ipsilateral to the cortex.

Structure Sub-components Origin
Striatum Caudate nucleus + Putamen Telencephalon
Globus Pallidus External (GPe), Internal (GPi) Telencephalon
Substantia Nigra Pars compacta (SNpc), Pars reticulata (SNpr) Midbrain
Subthalamic Nucleus N/A Diencephalon

2. Pathway Physiology & Disinhibition

Both pathways rely on GABAergic inhibition and ultimately influence the motor cortex via the thalamic VL nucleus.

Feature Direct Pathway (Promotion) Indirect Pathway (Suppression)
Mechanism Cortex → Striatum → inhibits GPi → disinhibits Thalamus Striatum → inhibits GPe → disinhibits STN → activates GPi → inhibits Thalamus
Dopamine D1 → Excites pathway D2 → Inhibits pathway
Acetylcholine Minimal role Activates the indirect pathway
Net Effect ↑ Movement (facilitation) ↓ Movement (suppression)

Core Concept:
Movement is controlled by disinhibition — inhibiting an inhibitor results in activation.

3. Clinical Correlate: Movement Disorders

Disorders arise from an imbalance between the direct and indirect pathways.

A. Direct Pathway Lesions (Hypokinetic)

Reduced cortical stimulation → decreased movement

Condition Pathology Clinical Features & Treatment
Parkinson Disease Loss of DA neurons in SNpc; Lewy bodies (α-synuclein) Pill-rolling tremor, rigidity, masked facies, bradykinesia, festinating gait
Rx: Levodopa, anticholinergics

B. Indirect Pathway Lesions (Hyperkinetic)

Excess cortical activity → increased involuntary movement

Condition Pathology Key Features
Huntington Disease CAG repeat (Chr 4); Caudate degeneration Chorea, dementia, behavioral changes, anticipation
Hemiballismus Lesion of contralateral STN Violent, flinging limb movements
Wilson Disease Copper accumulation; Putamen damage Wing-beating tremor, Kayser-Fleischer rings, liver disease
Rx: Penicillamine
Dystonia Basal ganglia dysfunction Sustained muscle contractions (e.g., torticollis)
Tourette Syndrome Dopamine dysregulation Motor & vocal tics are associated with OCD, ADHD

Clinical Pearls:

  • Disinhibition Rule: The basal ganglia work by inhibiting inhibitors — this is the key to understanding all pathways.
  • D1 vs D2 Mnemonic:
    • D1 = Direct = Do movement
    • D2 = Indirect = Don’t move
  • STN Lesion: Think “Ballistic” → Hemiballismus
  • Caudate Atrophy: Classic for Huntington’s disease (seen on imaging)
  • ↓ Dopamine → Parkinson’s → Hypokinetic
  • ↓ Indirect pathway activity → Hyperkinetic disorders

Check Your Knowledge: